{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:22:31Z","timestamp":1791195751925,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Italian Ministry for University and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.xphs.2019.11.011","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:21:58Z","timestamp":1574076118000},"page":"1297-1302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pentamidine-Loaded Lipid and Polymer Nanocarriers as Tunable Anticancer Drug Delivery Systems"],"prefix":"10.1016","volume":"109","author":[{"given":"Barbara","family":"Stella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Andreana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Zonari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Arpicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2019.11.011_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1471-4922(03)00069-2","article-title":"Pentamidine uptake and resistance in pathogenic protozoa: past, present and future","volume":"19","author":"Bray","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.xphs.2019.11.011_bib2","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.2147\/IJN.S140363","article-title":"Nanostructured delivery systems with improved leishmanicidal activity: a critical review","volume":"12","author":"Bruni","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.xphs.2019.11.011_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/med.20000","article-title":"DNA minor groove binders as potential antitumor and antimicrobial agents","volume":"24","author":"Baraldi","year":"2004","journal-title":"Med Res Rev"},{"issue":"14","key":"10.1016\/j.xphs.2019.11.011_bib4","first-page":"1255","article-title":"Pentamidine is an inhibitor of PRL phosphatases with anticancer activity","volume":"1","author":"Pathak","year":"2002","journal-title":"Mol Cancer Ther"},{"issue":"23","key":"10.1016\/j.xphs.2019.11.011_bib5","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1158\/0008-5472.CAN-07-2235","article-title":"The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.xphs.2019.11.011_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1158\/1535-7163.911.3.8","article-title":"The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer","volume":"3","author":"Chow","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.xphs.2019.11.011_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CAD.0b013e3283340cee","article-title":"The effect of pentamidine on melanoma ex\u00a0vivo","volume":"21","author":"Smith","year":"2010","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.xphs.2019.11.011_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2011.01.008","article-title":"Pentamidine reduces expression of hypoxia-inducible factor-1alpha in DU145 and MDA-MB-231 cancer cells","volume":"303","author":"Jung","year":"2011","journal-title":"Cancer Lett"},{"issue":"11","key":"10.1016\/j.xphs.2019.11.011_bib9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.leukres.2012.07.017","article-title":"Pentamidine sensitizes chronic myelogenous leukemia K562 cells to TRAIL-induced apoptosis","volume":"36","author":"Qiu","year":"2012","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.xphs.2019.11.011_bib10","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1158\/1535-7163.MCT-13-0750","article-title":"Computational repositioning and preclinical validation of pentamidine for renal cell cancer","volume":"13","author":"Zerbini","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.xphs.2019.11.011_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jac\/33.4.803","article-title":"Plasma pentamidine concentrations vary between individuals with Pneumocystis carinii pneumonia and the drug is actively secreted by the kidney","volume":"33","author":"Lidman","year":"1994","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.xphs.2019.11.011_bib12","first-page":"907593","article-title":"Nebulized pentamidine-induced acute renal allograft dysfunction","volume":"2013","author":"Prabhavalkar","year":"2013","journal-title":"Case Rep Transpl"},{"issue":"8","key":"10.1016\/j.xphs.2019.11.011_bib13","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/jbm.b.34058","article-title":"\u201cClick\u201d on PLGA-PEG and hyaluronic acid: gaining access to anti-leishmanial pentamidine bioconjugates","volume":"106","author":"Scala","year":"2018","journal-title":"J\u00a0Biomed Mater Res B Appl Biomater"},{"issue":"3","key":"10.1016\/j.xphs.2019.11.011_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/08982104.2017.1376682","article-title":"Liposomal formulations in the pharmacological treatment of leishmaniasis: a review","volume":"27","author":"Ortega","year":"2017","journal-title":"J\u00a0Liposome Res"},{"issue":"2","key":"10.1016\/j.xphs.2019.11.011_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1166\/jbn.2017.2349","article-title":"Nanotechnological strategies for treatment of leishmaniasis--a review","volume":"13","author":"de Almeida","year":"2017","journal-title":"J\u00a0Biomed Nanotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2019.11.011_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/21691401.2019.1596923","article-title":"Comparative in\u00a0vitro transportation of pentamidine across the blood-brain barrier using polycaprolactone nanoparticles and phosphatidylcholine liposomes","volume":"47","author":"Omarch","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.11.011_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2015.04.060","article-title":"Development of a liposome formulation for improved biodistribution and tumor accumulation of pentamidine for oncology applications","volume":"488","author":"Merian","year":"2015","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2019.11.011_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1667\/RR14315.1","article-title":"Dual action enhancement of gold nanoparticle radiosensitization by pentamidine in triple negative breast cancer","volume":"185","author":"Her","year":"2016","journal-title":"Radiat Res"},{"issue":"4","key":"10.1016\/j.xphs.2019.11.011_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040195","article-title":"Strategies to obtain encapsulation and controlled release of pentamidine in mesoporous silica nanoparticles","volume":"10","author":"Peretti","year":"2018","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.xphs.2019.11.011_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/toxics5040029","article-title":"Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in\u00a0vitro\/in\u00a0vivo toxicity evaluation","volume":"5","author":"De Matteis","year":"2017","journal-title":"Toxics"},{"issue":"12","key":"10.1016\/j.xphs.2019.11.011_bib21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/polb.22259","article-title":"Biomedical applications of biodegradable polymers","volume":"49","author":"Ulery","year":"2011","journal-title":"J\u00a0Polym Sci B Polym Phys"},{"issue":"2","key":"10.1016\/j.xphs.2019.11.011_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2019.11.011_bib23","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2019.11.011_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.xphs.2019.11.011_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1023\/A:1020765615379","article-title":"Poly(D,L-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system","volume":"19","author":"Mandal","year":"2002","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2019.11.011_bib26","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.xphs.2019.11.011_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/38.1.145","article-title":"Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes","volume":"38","author":"Banerjee","year":"1996","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.xphs.2019.11.011_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/17425247.2011.566552","article-title":"Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in\u00a0vivo activity","volume":"8","author":"Gubernator","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2019.11.011_bib29","series-title":"Pentamidine Salts Useful Treatment Prophylaxis Pneumocystis Carinii Pneumonia","author":"Pai","year":"1989"},{"key":"10.1016\/j.xphs.2019.11.011_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0378-5173(97)00291-3","article-title":"Pentamidine-loaded poly(D,L-lactide) nanoparticles: physicochemical properties and stability work","volume":"159","author":"Paul","year":"1997","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2019.11.011_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/10611869808997874","article-title":"Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice","volume":"5","author":"Paul","year":"1998","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.xphs.2019.11.011_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2014.11.002","article-title":"Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis","volume":"197","author":"Arias","year":"2015","journal-title":"J\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.xphs.2019.11.011_bib33","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ijpharm.2016.08.011","article-title":"Design of smart GE11-PLGA\/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in\u00a0vitro\/ex\u00a0vivo characterization","volume":"511","author":"Colzani","year":"2016","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2019.11.011_bib34","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1248\/cpb.c14-00009","article-title":"Characterization of a doxorubicin liposome formulation by a novel in\u00a0vitro release test methodology using column-switching high-performance liquid chromatography","volume":"62","author":"Ohnishi","year":"2014","journal-title":"Chem Pharm Bull (Tokyo)"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919307543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919307543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:27:43Z","timestamp":1758360463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919307543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0022354919307543"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.11.011","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentamidine-Loaded Lipid and Polymer Nanocarriers as Tunable Anticancer Drug Delivery Systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}